8-K: Sensus Healthcare Secures $15M Revolving Credit Facility

Sensus Healthcare has entered into a new $15 million revolving credit facility with City National Bank of Florida to support working capital needs.

Summary

• Sensus Healthcare entered into a new $15 million revolving credit facility with City National Bank of Florida (CNB) on June 2, 2026.
• The facility replaces a previous revolving credit facility with Fifth Third Bank, N.A.
• The loan is secured by a first-priority security interest in all business assets and a $2,230,000 cash collateral account.
• Initial borrowing is limited to $2,000,000, with the remaining $13,000,000 restricted until specific financial performance criteria are met.
• The loan matures on June 5, 2027, and bears interest at the Secured Overnight Financing Rate (SOFR) plus 3%.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral development; while it secures necessary liquidity, the restrictive covenants and cash collateral requirements highlight a constrained financial position.

Positives

• Secures necessary working capital liquidity through a new credit facility.
• Provides a clear path to access the full $15 million commitment upon meeting defined financial performance milestones.
• Maintains a banking relationship to support ongoing operations.

Negatives

• Requires $2,230,000 in cash to be held as restricted collateral, reducing immediate liquidity.
• Imposes restrictive covenants, including a minimum debt service coverage ratio (DSCR) of 1.50.
• Limits management flexibility by requiring lender consent for asset transfers, additional indebtedness, and changes to key executive roles.

Risks

• Potential for acceleration of the loan and termination of the facility upon an Event of Default.
• Interest rate risk due to the variable nature of the SOFR-based interest rate.
• Operational constraints due to restrictive covenants regarding asset management and executive leadership changes.
• Risk of failing to meet the 1.50 DSCR requirement, which would necessitate reducing principal or providing additional cash collateral.

Future Outlook

The company intends to use the facility for working capital. Access to the full $13 million restricted portion of the loan is contingent upon achieving four consecutive quarters of positive net income and maintaining a 1.50 DSCR.

Management Comments

• The company has entered into this agreement to secure working capital needs.

Industry Context

StockSavvy.ai notes that this transition to a new lender and the requirement for significant cash collateral suggests a tightening of credit terms for the company compared to its previous facility, reflecting a conservative approach by the lender in the current interest rate environment.

Comparison to Industry Standards

• The requirement for cash collateral is a more restrictive covenant than standard unsecured revolving credit facilities for established public companies.
• The 1.50 DSCR requirement is a standard benchmark for mid-market corporate lending.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential dilution risk if profitability targets are not met and alternative financing is required.
• Creditors: The company has prioritized this lender with a first-priority security interest in all assets.

Next Steps

• Establishment and funding of the $2,230,000 cash collateral account.
• Quarterly testing of the 1.50 DSCR covenant.
• Potential future request for the release of the $13 million restricted commitment upon meeting profitability milestones.

Key Dates

Recommendation

The company has secured necessary liquidity, but the restrictive nature of the loan and the need for cash collateral suggest limited financial flexibility in the near term.

Keywords

Sensus Healthcare, revolving credit facility, City National Bank of Florida, working capital, debt financing, SEC filing, SRTS